1. FRI0588 Comparing The Burden of Illness of Patients with Tophaceous and Non-Tophaceous Gout in France, Germany, Italy, Spain, and The UK. (15th July 2016) Authors: Khanna, P.; Tafesse, E.; Baumgartner, S.; Walker, A.; Morlock, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0589 The Impact of Gout Flares on Patient-Reported Assessments of Pain and Disability. (15th July 2016) Authors: Khanna, P.; Baumgartner, S.; Robinson, J.; Tafesse, E.; Morlock, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0527 Lesinurad, A Selective Uric Acid Reabsorption Inhibitor, in Combination with Xanthane Oxidase Inhibitors: SUA and Flares Composite Endpoint from Phase III Studies in Gout Patients (Clear 1, Clear 2 and Crystal). (15th July 2016) Authors: Khanna, P.P.; Baumgartner, S.; Robinson, J.; Tafesse, E.; Morlock, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗